JENNIFER JARIS-WEAVER: Open Payments
NPI 1821012923 · MADISON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 51 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $252 · 2025 $1,080
Food & beverage: $1,080
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $362 |
| Abbott Laboratories | 1 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| PFIZER INC. | 6 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $76 |
| Amgen Inc. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Radius Health, Inc. | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $33 |
Products named: Ozempic, Wegovy, AVEIR, NURTEC ODT, Kerendia, FARXIGA, OTEZLA, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
